165 related articles for article (PubMed ID: 1156520)
1. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
Sadler TE; Castro JE
Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
[No Abstract] [Full Text] [Related]
2. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
Karrer K; Rella W; Goldin A
Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
[No Abstract] [Full Text] [Related]
3. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
[No Abstract] [Full Text] [Related]
4. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
Yuhas JM; Ullrich RL
Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
[TBL] [Abstract][Full Text] [Related]
5. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
Sadler TE; Castro JE
Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
[No Abstract] [Full Text] [Related]
6. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
Scott MT
J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
[No Abstract] [Full Text] [Related]
7. Antitumor activity of Corynebacterium parvum.
Milas L; Scott MT
Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
[No Abstract] [Full Text] [Related]
8. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
Conley FK; Remington JS
J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
[No Abstract] [Full Text] [Related]
9. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
Woodruff MF; McBride WH; Dunbar N
Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
[TBL] [Abstract][Full Text] [Related]
10. Effects of Corynebacterium parvum on tumour metastases in mice.
Castro JE
Br J Surg; 1977 Oct; 64(10):721-4. PubMed ID: 922293
[No Abstract] [Full Text] [Related]
11. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
Scott MT
J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
[No Abstract] [Full Text] [Related]
12. [Effect of immunostimulation by Corynebacterium parvum on evolution and metastatic dissemination of Lewis's tumor in mouse C57BL/6 mice].
Pot-Deprun J; Chouroulinkov I
C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):685-8. PubMed ID: 809167
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of concomitant immunity after radiation therapy and immunotherapy in a syngeneic murine tumour system.
Deneufbourg JM
Acta Radiol Oncol; 1982; 21(5):345-8. PubMed ID: 6297254
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Immunological control of cancer.
Lancet; 1975 Mar; 1(7905):502-3. PubMed ID: 46965
[No Abstract] [Full Text] [Related]
15. Letter: Immunological control of cancer.
Israel L; Edelstein R
Lancet; 1975 Apr; 1(7913):979-10. PubMed ID: 48154
[No Abstract] [Full Text] [Related]
16. Organ distribution of Corynebacterium parvum labeled with iodine-125.
Dimitrov NV; Greenberg CS; Denny T
J Natl Cancer Inst; 1977 Feb; 58(2):287-94. PubMed ID: 833877
[TBL] [Abstract][Full Text] [Related]
17. The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases.
Sadler TE; Castro JE
Br J Surg; 1976 Apr; 63(4):292-6. PubMed ID: 1276661
[TBL] [Abstract][Full Text] [Related]
18. Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
O'Neill GJ; Stebbing N
Br J Cancer; 1980 Feb; 41(2):243-9. PubMed ID: 7370164
[TBL] [Abstract][Full Text] [Related]
19. Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria.
Ojo E
Cell Immunol; 1979 Jun; 45(1):182-7. PubMed ID: 455483
[No Abstract] [Full Text] [Related]
20. Morphological and functional aspects of active specific immunotherapy of established pulmonary metastases in guinea pigs.
Hanna MG; Peters LC
Cancer Res; 1981 Oct; 41(10):4001-9. PubMed ID: 7285011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
